During the past decade, Billings Clinic Research Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 19 clinical trials were completed, i.e. on average, 211.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Billings Clinic Research Center" #1 sponsor was "Mannkind Corporation" with 9 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Abbott" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Billings Clinic Research Center" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Billings Clinic Research Center" are "Crohn's Disease" (4 trials), "Alzheimer's Disease" (3 trials), "Type 2 Diabetes" (3 trials), "Diabetes Mellitus, Type 1" (2 trials) and "Diabetes, Type 1" (2 trials). Many other conditions were trialed in "Billings Clinic Research Center" in a lesser frequency.

Most popular intervention types in "Billings Clinic Research Center" are "Drug" (30 trials), "Biological" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Technosphere Insulin" (4 trials), "Abemaciclib" (3 trials), "Atezolizumab" (3 trials) and "Technosphere® Insulin Inhalation Powder" (3 trials). Other intervention names were less common.

The vast majority of trials in "Billings Clinic Research Center" are 32 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Billings Clinic Research Center". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Billings Clinic Research Center, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Billings Clinic Research Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".